Comparison of Efficacy of Nifedipine Alone Versus Nifedipine and Progesterone in the Treatment of Threatened Preterm Labour
DOI:
https://doi.org/10.36283/ziun-pjmd15-2/019Keywords:
preterm labor, nifedipine, progesterone, tocolysis, uterine contractionsAbstract
Background: One of the main causes of infant morbidity and mortality is preterm birth, which is defined as delivery before 37 weeks of gestation. Tocolytic therapy is essential to delay delivery, allowing corticosteroid administration for fetal lung maturation. Nifedipine is an effective tocolytic, and progesterone may enhance uterine quiescence.
Methods: A prospective comparative study was conducted at Shifa International Hospital, Islamabad, over 12 months. A total of 130 women with singleton pregnancies between 24–37 weeks diagnosed with threatened preterm labor were enrolled and assigned to treatment groups based on clinical management: Group A received nifedipine alone, and Group B received nifedipine plus progesterone. Uterine contractions and maternal side effects were monitored. Data were analyzed using SPSS v22, with chi-square and t-tests applied; p≤0.05 was considered significant.
Results: Cessation of contractions within 48 hours occurred in 47.7% of Group A and 72.3% of Group B (χ²=8.56, p=0.003). Mean time to cessation was shorter in Group B (21.7 ± 7.0 hours) than Group A (29.4 ± 8.2 hours, t=3.38, p=0.001). Maternal side effects were mild; vaginal discomfort occurred only in the combination group (7.7%, p=0.03). Stratification by age, parity, and gestational age did not alter these outcomes.
Conclusion: Nifedipine combined with progesterone was more effective than nifedipine alone for threatened preterm labor, with minimal side effects, suggesting a safe and efficient approach to improve maternal and neonatal outcomes.
References
1. Ahmed AM, Grandi SM, Pullenayegum E, McDonald SD, Beltempo M, Premji SS, Pole JD, Bacchini F, Shah PS, Pechlivanoglou P. Short-term and long-term mortality risk after preterm birth. JAMA network open. 2024 Nov 4;7(11):e2445871-.doi.org/10.1001/jamanetworkopen.2024.45871
2. Salam, S.S., Ameen, S., Balen, J., Nahar, Q., Jabeen, S., Ahmed, A., Gillespie, B., Chauke, L., Mannan, A., Hoque, M. and Dey, S.K., 2023. Research prioritisation on prevention and management of preterm birth in low and middle-income countries (LMICs) with a special focus on Bangladesh using the Child Health and Nutrition Research Initiative (CHNRI) method. Journal of Global Health, 13, p.07004.doi.org/10.7189/jogh.13.07004
3. Wong TT, Yong X, Tung JS, Lee BJ, Chan JM, Du R, Yeo TW, Yeo GS. Prediction of labour onset in women who present with symptoms of preterm labour using cervical length. BMC Pregnancy and Childbirth. 2021 May 5;21(1):359.doi.org/10.1186/s12884-021-03828-z
4. Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, Price MJ. Tocolytics for delaying preterm birth: a network meta‐analysis (0924). Cochrane Database of Systematic Reviews. 2022(8).doi.org/10.1002/14651858.CD014978.pub2
5. Zamani M, Alimi R, Arabi SM, Moradi M, Azmoude E. Comparison of the efficacy of nifedipine with ritodrine, nitroglycerine and magnesium sulfate for the management of preterm labor: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 2024 Apr 25;24(1):318.doi.org/10.1186/s12884-024-06497-w
6. Yamaji N, Suzuki H, Saito K, Swa T, Namba F, Vogel JP, Ramson JA, Cao J, Tina L, Ota E. Tocolytic therapy inhibiting preterm birth in high-risk populations: a systematic review and meta-analysis. Children. 2023 Feb 24;10(3):443.doi.org/10.3390/children10030443
7. van Winden TM, Nijman TA, Kleinrouweler CE, Salim R, Kashanian M, Al-Omari WR, Pajkrt E, Mol BW, Oudijk MA, Roos C. Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis. BMC Pregnancy and Childbirth. 2022 Jul 15;22(1):567.doi.org/10.1186/s12884-022-04854-1
8. Mazza GR, Komatsu E, Ponzio M, Bai C, Cortessis VK, Sasso EB. Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study. BMC Pregnancy and Childbirth. 2024 Apr 8;24(1):252.doi.org/10.1186/s12884-024-06471-6
9. Essa M, Sami KH, Rana JA, Masaud I, Malik MU, Aslam B, Falah NU, Shoaib U, Akhtar H, Abid HM, Mahmood MS. Comparison of Efficacy of Nifedipine Alone and Nifedipine with Progesterone Depot for Tocolysis of Preterm Labour. Journal of Health and Rehabilitation Research. 2024 Aug 8;4(3):1-7.doi.org/10.61919/jhrr.v4i3.1307
10. Jikria N, Sayeeda N, Ahmed A, Mili FS, Salma U. A Comparative study in Suppression of Preterm Labor with Nifedipine vs Salbutamol: A Quasi-Experimental study. Bangladesh Journal of Obstetrics & Gynaecology. 2023;38(2):78-83.doi.org/10.3329/bjog.v38i2.82097
11. Paul M, Barreda AP, Gregson A, Kahl R, King M, Hussein WM, Walker FR, Smith R, Zakar T, Paul JW. Regulation of 20α-Hydroxysteroid Dehydrogenase Expression in Term Pregnant Human Myometrium Ex Vivo. Reproductive Sciences. 2024 Jan;31(1):150-61.doi.org/10.1007/s43032-023-01333-6
12. Karya U, Rani A, Srivastava A. Tocolytic effect of combined sildenafil citrate and nifedepine versus nifedipine alone for management of preterm labour at a tertiary centre. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2021;10(4):1597.doi.org/10.18203/2320-1770.ijrcog20211143
13. Manouchehri E, Makvandi S, Razi M, Sahebari M, Larki M. Efficient administration of a combination of nifedipine and sildenafil citrate versus only nifedipine on clinical outcomes in women with threatened preterm labor: a systematic review and meta-analysis. BMC pediatrics. 2024 Feb 10;24(1):106.doi.org/10.1186/s12887-024-04588-3
14. Hossain MR, Paul M, Tolosa JM, Smith R, Paul JW. Preventing Preterm Birth: The Search for Tocolytic Synergism. Reproductive Sciences. 2025 Aug 25:1-25.doi.org/10.1007/s43032-025-01941-4
15. Singh S, Tyagi P, Anand D, Gupta N, Gupta R. A comparative study of efficacy and side effects of nifedipine with nifedipine along with dydrogesterone in management of preterm labor. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2023;12(6):1671.doi.org/10.18203/2320-1770.ijrcog20231534
16. Haghighi L, Rashidi M, Najmi Z, Homam H, Hashemi N, Mobasseri A, Moradi Y. Comparison of intramuscular progesterone with oral nifedipine for treating threatened preterm labor: A randomized controlled trial. Medical journal of the Islamic Republic of Iran. 2017 Sep 6;31:56.doi.org/10.14196/mjiri.31.56
17. Ashraf B. Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor. International journal of reproductive biomedicine. 2019 Sep 22;17(9):629.doi.org/10.18502/ijrm.v17i9.5098
18. Ikechebelu JI, Dim CC, Eleje GU, Joe-Ikechebelu N, Okpala BC, Okam PC. A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles. Journal of Medicine and Life. 2023 Jan;16(1):62.doi.org/10.25122/jml-2022-0131
19. El-Sayed MA, Abdelgaied AM, Fathey AA, El-Shemy EM. Nifedipine versus Nifedipine and Progesterone Therapy in Acute Tocolysis in Preterm Labor and Their Effect on Maternal and Fetal blood flow. The Egyptian Journal of Hospital Medicine. 2021 Jan 1;82(4):668-74.doi.org/10.21608/ejhm.2021.150440
Published
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
